Nan, D. et al. (2021) “Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report”, European Journal of Case Reports in Internal Medicine, 8(10). doi:10.12890/2021_002821.